| Dr Michael William Gilliland, MD | |
|
1322 3rd St Se, Suite 100, Puyallup, WA 98372-3771 | |
| (253) 697-4128 | |
| Not Available |
| Full Name | Dr Michael William Gilliland |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology - Pain Medicine |
| Location | 1322 3rd St Se, Puyallup, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063426005 | NPI | - | NPPES |
| 20202185198372A002 | Other | WA | TRICARE ID |
| 1322GI | Other | WA | REGENCE BLUE SHIELD ID |
| 1119296 | Medicaid | WA | |
| P00257376 | Other | WA | RAILROAD MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | MD00042973 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael William Gilliland, MD 1498 Se Tech Center Pl, Suite 340, Vancouver, WA 98683-9591 Ph: (360) 260-0235 | Dr Michael William Gilliland, MD 1322 3rd St Se, Suite 100, Puyallup, WA 98372-3771 Ph: (253) 697-4128 |
News Archive
Tikcro Technologies Ltd. today announced that BioCancell reported results from a Phase I/IIa clinical trial to establish the safety, optimal dose and preliminary efficacy of BioCancell's lead drug-candidate, BC-819, as a treatment for pancreatic cancer.
Studies suggest that neurotrophic factors, which play a role in the development and survival of neurons, have significant therapeutic and restorative potential for neurologic diseases such as Huntington's disease. However, clinical applications are limited because these proteins cannot easily cross the blood brain barrier, have a short half-life, and cause serious side effects.
Recent reports suggesting a link between long-term bisphosphonate usage and rare bone fractures have sparked rising concern among patients, health care professionals and the public. The American Society of Bone and Mineral Research (ASBMR) is examining this urgent clinical issue and will present its findings later this year.
Researchers from the Center for Genomic Sciences at Allegheny General Hospital (AGH) in Pittsburgh have made a landmark discovery about the evolutionary nature of bacteria in the setting of chronic infectious disease. Reporting today in the journal PLos Pathogens, the AGH team documents for the first time that bacteria engage in a process called horizontal gene transfer to evolve rapidly during the course of a single infection.
› Verified 8 days ago
Christina Julian, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se Ste 101, Puyallup, WA 98372 Phone: 253-841-8939 Fax: 253-841-5944 | |
Will O Blankenship, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 E Pioneer, Ste. 208, Puyallup, WA 98372 Phone: 253-445-5828 | |
Thomas P Kennedy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 E Pioneer, Ste 208, Puyallup, WA 98372 Phone: 253-445-5828 | |
William R Rinker, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 E Pioneer Ste 101, Puyallup, WA 98372 Phone: 253-445-5828 | |
Dr. Kathy I-wen Wang, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1519 3rd St Se Ste 101, Puyallup, WA 98372 Phone: 253-841-8939 Fax: 253-841-5944 | |
Michael D Cull, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 E Pioneer, Ste 208, Puyallup, WA 98372 Phone: 253-445-5828 |